Asciminib Hydrochloride

Brand name: Scemblix

Rank #408 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$21.4M

Total Cost

Share:

830

Total Claims

$21.4M

Total Cost

59

Prescribers

$26K

Cost per Claim

0

Beneficiaries

846

30-Day Fills

$363K

Avg Cost/Provider

14

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$21.4M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $21.4M total

🔎 Data Overview

💰

At $25,822 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $363,257 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Asciminib Hydrochloride

#ProviderSpecialtyLocationClaimsCost
1Luis ConcepcionHematology-OncologyPaducah, KY11$1.2M
2Saji EapenHematology-OncologyKnoxville, TN11$1.2M
3Krista TuckerNurse PractitionerBoston, MA15$1.1M
4Mayda AriasHematology-OncologyFt Lauderdale, FL13$988K
5Pablo BedanoHematology-OncologyIndianapolis, IN38$733K
6Kristen KindervaterPhysician AssistantAnn Arbor, MI12$692K
7Raphael LizcanoHematology-OncologyLebanon, NH11$679K
8Christine McmahonHematology-OncologyAurora, CO24$514K
9Camille AbboudMedical OncologySaint Louis, MO23$496K
10Joshua ZeidnerHematology-OncologyChapel Hill, NC22$471K
11Daniel DeangeloMedical OncologyBoston, MA23$447K
12Todd RosenblatHematologyNew York, NY20$442K
13Raymund CuevoMedical OncologyFairfax, VA20$434K
14Jeremy WellsHematology-OncologyAugusta, GA18$401K
15Christopher BentonMedical OncologyEnglewood, CO17$365K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
405Tolterodine Tartrate (Tolterodine Tartrate Er)$21.8M178,340
406Chlorthalidone (Chlorthalidone)$21.8M966,780
407Ondansetron (Ondansetron Odt)$21.5M1,261,950
408Asciminib Hydrochloride (Scemblix)$21.4M830
409Cephalexin (Cephalexin)$21.4M2,407,718
410Teprotumumab-Trbw (Tepezza)$21.4M389
411Nystatin (Nystatin)$21.4M908,177

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology